Brooks Laboratories (BROOKS) Share Price rises 9.24% as Brooks Laboratories Share Price hits Rs 70.67

Brooks Laboratories Share Price is in focus after the stock rose 9.24% to Rs 70.67 from Rs 64.69, taking the company’s market capitalisation to Rs 193.48 crore. Brooks Laboratories Share Price Today is notable because the move came without a company-specific catalyst being established in the verified data. The price move is confirmed in Univest data; a company-specific reason has not been established. For readers tracking Brooks Laboratories Share Price News, the main question is not only the price rise, but what the company’s valuation and return ratios say about the move. Brooks Laboratories Share Price now sits at a level that can be read alongside its P/E, P/B, ROE and ROCE, all of which help place today’s share price gain in context. Investors monitoring Brooks Laboratories Share Price can also compare it with the healthcare and pharmaceuticals peer set.

In Univest coverage, Brooks Laboratories Share Price Today is best understood through the mix of price action, fundamentals and sector context. The stock opened at Rs 67, touched a high of Rs 71.69 and a low of Rs 65.92, which frames the day’s range clearly for Brooks Laboratories Share Price watchers. With no verified catalyst stated, the focus shifts to what the latest Univest figures show about Brooks Laboratories Share Price and whether valuation support is visible against industry benchmarks. That makes Brooks Laboratories Share Price News useful for investors who want facts first and commentary second.

Brooks Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 70.67
Previous Close	Rs 64.69
Today's Move	Rs 5.98 (+9.24%)
Open	Rs 67
High	Rs 71.69
Low	Rs 65.92
Market Capitalisation	Rs 193.48 crore
Market Cap Category	Micro Cap

Brooks Laboratories Ltd. (BROOKS) rose to Rs 70.67 from the previous close of Rs 64.69, a move of Rs 5.98 or 9.24%. The stock opened at Rs 67, reached a high of Rs 71.69, recorded a low of Rs 65.92.

Brooks Laboratories Share Price Today shows a firm intraday rise, with the stock trading at Rs 70.67 after moving Rs 5.98 higher from the previous close of Rs 64.69. Brooks Laboratories Share Price also opened at Rs 67, touched a high of Rs 71.69 and a low of Rs 65.92, so the day’s range has already captured a clear upward move. Brooks Laboratories Share Price Today is therefore not a marginal move; it is a visible share price gain that places the stock among the day’s notable movers in healthcare. The market capitalisation at Rs 193.48 crore adds size context to the price rise. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. For Brooks Laboratories Share Price, the next useful step is to compare this move with fundamentals.

Brooks Laboratories Share Price Today matters because the stock is not moving in isolation from its base level. The gap between the previous close and the current trade shows the exact price rise, while the opening level and intraday high-low band show how far the stock has travelled during the ongoing session. Brooks Laboratories Share Price News therefore starts with price action, then moves naturally into Brooks Laboratories Share Price Fundamental Analysis.

Brooks Laboratories Ltd. (BROOKS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 193.48 crore
P/E Ratio	14.42x
P/B Ratio	1.54x
ROE	22.27%
ROCE	21.72%
EPS	Rs 4.49
Book Value Per Share	Rs 42.12
Dividend Yield	0%

Brooks Laboratories Ltd. (BROOKS) fundamental metrics show P/E 14.42x, P/B 1.54x, ROE 22.27%, ROCE 21.72%. These ratios show where the company stands today and are not a call to buy or sell.

Brooks Laboratories Ltd. has a market capitalisation of Rs 193.48 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 14.42x, P/B at 1.54x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 22.27% and ROCE of 21.72%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 4.49, book value per share of Rs 42.12, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.72x, median ROE of 11.61%, median ROCE of 13.46%. Together they describe the fundamental backdrop without implying a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	14.42x
Benchmark Median P/E	31.72x
Benchmark Average P/E	46.74x
Benchmark P/E Range	3.11x to 663.29x
Company P/B Ratio	1.54x
Benchmark Median P/B	2.91x
Company ROE	22.27%
Benchmark Median ROE	11.61%
Company ROCE	21.72%
Benchmark Median ROCE	13.46%
Company Market Capitalisation	Rs 193.48 crore
Benchmark Median Market Cap	Rs 821.94 crore

Brooks Laboratories Ltd. (BROOKS) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Brooks Laboratories Ltd. (BROOKS) has a P/E ratio of 14.42x, which is below the benchmark median of 31.72x, a difference of -54.54%. A P/E difference of this kind is a reference point rather than a recommendation.

Brooks Laboratories Ltd. (BROOKS) has a ROE of 22.27%, which is above the benchmark median of 11.61%, a difference of +91.82%. Brooks Laboratories Ltd. (BROOKS) has a ROCE of 21.72%, which is above the benchmark median of 13.46%, a difference of +61.37%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,22,067.01	35.09	4.91	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,48,982.98	84.18	13.94	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,77,974.12	80.83	19.64	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,13,615.69	25	4.18	19.69	21.39
Laurus Labs Ltd.	LAURUSLABS	1,11,898.66	101.36	19.65	18.31	18.2

Brooks Laboratories Ltd. (BROOKS) has a P/E ratio of 14.42x compared with the displayed peer median of 80.83x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 22.27% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 21.72% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Brooks Laboratories Ltd. (BROOKS) has a market capitalisation of Rs 193.48 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Brooks Laboratories

• Brooks Laboratories Share Price rose 9.24% to Rs 70.67, making the stock a clear price-rise story today.
• Brooks Laboratories Share Price is trading with a market capitalisation of Rs 193.48 crore, which helps frame the scale of the move.
• Brooks Laboratories Share Price shows P/E of 14.42 and P/B of 1.54, both below the same-industry benchmark medians.
• Brooks Laboratories Share Price has ROE of 22.27% and ROCE of 21.72%, which are above the benchmark medians and averages.
• Brooks Laboratories Share Price News remains relevant because no company-specific catalyst is established, so price action and fundamentals matter most.

About Brooks Laboratories

Brooks Laboratories Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. Brooks Laboratories Share Price investors typically track the business through its core financial profile rather than through a broad consumer-facing model. The company’s current market capitalisation, return ratios and valuation metrics help define Brooks Laboratories Share Price context more precisely than a generic industry label would. In this article type, the company is viewed through the latest Univest figures on price, market cap and fundamentals, which is useful because Brooks Laboratories Share Price Today needs both business context and valuation context.

Brooks Laboratories Share Price is therefore linked to a healthcare company whose analysis rests on ratios such as P/E, P/B, ROE and ROCE, plus book value and EPS. The company description is intentionally kept factual: it belongs to the pharmaceuticals universe, and its latest metrics are relevant because they allow Brooks Laboratories Share Price to be compared against sector and peer benchmarks. For readers following Brooks Laboratories Share Price News, the company overview sits best beside the day’s move and the valuation data.

Frequently Asked Questions

What is Brooks Laboratories Share Price today?

Ans. Brooks Laboratories Share Price is Rs 70.67, up 9.24% from the previous close of Rs 64.69. The move also lifted market capitalisation to Rs 193.48 crore, keeping the stock in focus during the ongoing session.

Why is Brooks Laboratories Share Price rising today?

Ans. The price move is confirmed in Univest data; a company-specific reason has not been established. Brooks Laboratories Share Price is higher on the day, so the verified explanation remains the intraday price action itself.

What was Brooks Laboratories Share Price previous close?

Ans. The previous close for Brooks Laboratories Share Price was Rs 64.69. The current trade at Rs 70.67 shows a rise of Rs 5.98, which is the exact change recorded in the latest Univest figures.

What are the key valuation metrics for Brooks Laboratories Share Price?

Ans. Brooks Laboratories Share Price has a P/E ratio of 14.42 and a P/B ratio of 1.54. These figures sit below the same-industry benchmark medians, which gives the stock a lower valuation profile than many peers.

How do ROE and ROCE look for Brooks Laboratories Share Price?

Ans. Brooks Laboratories Share Price shows ROE of 22.27% and ROCE of 21.72%. Both are above the same-industry benchmark median and average, so the return profile compares well with the broader Pharmaceuticals & Drugs set.

What is the market capitalisation of Brooks Laboratories Share Price?

Ans. Brooks Laboratories Share Price has a market capitalisation of Rs 193.48 crore. Within the same-industry benchmark, that is below the median market cap of Rs 821.94 crore, which places the company on the smaller side of the group.

How does Brooks Laboratories Share Price compare with peers?

Ans. Brooks Laboratories Share Price has a lower P/E and P/B than Sun Pharmaceutical, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Laurus Labs in the peer set shown. Its ROE and ROCE also compare favourably with several of those names.

What do EPS and book value mean for Brooks Laboratories Share Price?

Ans. Brooks Laboratories Share Price has EPS of 4.49 and book value of Rs 42.12. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share at the current point in time.

Track Brooks Laboratories Share Price on Univest

Use Brooks Laboratories Ltd. (BROOKS) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track Brooks Laboratories Share Price on Univest for live share price movement, fundamental ratios, 52-week levels and market insights in one place. Brooks Laboratories Share Price Today is most useful when price action is read alongside the company’s valuation, returns and sector benchmark. Univest keeps Brooks Laboratories Share Price analysis focused on the numbers that matter most.